13F-HR filed by Tekla Capital Management LLC
Tekla Capital Management LLC filed this 13F-HR for the quarter ended 2014-06-30, filed 2014-08-05, with 64 holding rows worth $1,089,505,000.
- Accession
- 0001104659-14-056874
- Filer
- CIK 1300336
- Filed
- 2014-08-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2014
A holdings report, 64 entries on the cover page, a total value of $1,089,505,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,089,505,000 with VALUE read as thousands by filing date, 13F file number 028-10950. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 1,504,712 | $124,756,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 944,092 | $81,079,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 173,983 | $54,859,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 193,466 | $54,648,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 449,543 | $53,212,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 335,899 | $52,484,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 540,944 | $51,217,000 | thousands by filing date | |
| ACTAVIS PLC | G0083B108 | SHS | 205,707 | $45,883,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 768,238 | $43,359,000 | thousands by filing date | |
| MYLAN INC | 628530107 | COM | 652,209 | $33,628,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 123,322 | $29,041,000 | thousands by filing date | |
| ALLERGAN INC | 018490102 | COM | 156,627 | $26,504,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 421,384 | $26,214,000 | thousands by filing date | |
| AKORN INC | 009728106 | COM | 699,382 | $23,254,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 247,541 | $20,071,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 103,841 | $18,540,000 | thousands by filing date | |
| CUBIST PHARMACEUTICALS INC | 229678107 | COM | 263,772 | $18,417,000 | thousands by filing date | |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 65,184 | $16,754,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 311,476 | $16,328,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 95,957 | $14,107,000 | thousands by filing date | |
| CELLADON CORP | 15117E107 | Cmn | 970,495 | $13,215,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 255,970 | $12,883,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 67,862 | $12,637,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 768,050 | $11,774,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 790,490 | $11,731,000 | thousands by filing date | |
| FOREST LABS INC | 345838106 | COM | 109,875 | $10,878,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 873,940 | $10,767,000 | thousands by filing date | |
| ALERE INC | 01449J105 | COM | 286,540 | $10,722,000 | thousands by filing date | |
| SAGENT PHARMACEUTICALS INC | 786692103 | COM | 404,731 | $10,466,000 | thousands by filing date | |
| IMPAX LABORATORIES INC | 45256B101 | COM | 344,683 | $10,337,000 | thousands by filing date | |
| CATAMARAN CORP | 148887102 | COM | 231,000 | $10,201,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 334,957 | $9,942,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 202,600 | $9,828,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 212,541 | $9,486,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 62,952 | $9,176,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 126,215 | $8,838,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 680,746 | $8,673,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 918,827 | $8,325,000 | thousands by filing date | |
| REVVITY INC | 714046109 | COM | 165,495 | $7,752,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 225,762 | $7,610,000 | thousands by filing date | |
| IDEXX LABS INC COM | 45168D104 | Stock | 56,265 | $7,515,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 59,660 | $7,040,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 83,186 | $6,800,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 731,943 | $6,441,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 501,553 | $6,054,000 | thousands by filing date | |
| INTELLIPHARMACEUTICS INTERNA | 458173101 | CMN | 1,404,000 | $5,349,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 60,000 | $4,537,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 353,475 | $4,270,000 | thousands by filing date | |
| MERRIMACK PHARMACEUTICALS IN | 590328100 | COM | 567,787 | $4,139,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 61,595 | $3,891,000 | thousands by filing date | |
| NPS PHARMACEUTICALS INC | 62936P103 | COM | 82,900 | $2,740,000 | thousands by filing date | |
| INTERMUNE INC | 45884XAE3 | NOTE 2.500% 9/1 | 1,800,000 | $2,702,000 | thousands by filing date | principal |
| EPIZYME INC | 29428V104 | COM | 70,162 | $2,183,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 54,527 | $2,103,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 79,150 | $2,069,000 | thousands by filing date | |
| MERRIMACK PHARMACEUTICALS IN | 590328AA8 | NOTE 4.500% 7/1 | 1,485,000 | $1,966,000 | thousands by filing date | principal |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 47,364 | $1,961,000 | thousands by filing date | |
| KYTHERA BIOPHARMACEUTICALS I | 501570105 | COM | 49,000 | $1,880,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 120,400 | $1,839,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,005,000 | $1,769,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 243,920 | $1,546,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 31,857 | $692,000 | thousands by filing date | |
| ONCOGENEX PHARMACEUTICALS IN | 68230A106 | COM | 113,100 | $422,000 | thousands by filing date | |
| AEGERION PHARMACEUTICALS INC | 00767E102 | COM | 20 | $1,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-14-056874 | this filing | 2014-08-05 | acceptance time not in the bulk data set |